Open Access. Powered by Scholars. Published by Universities.®

Medicine and Health Sciences Commons

Open Access. Powered by Scholars. Published by Universities.®

Book Gallery

2017

Antineoplastic Agents

Articles 1 - 5 of 5

Full-Text Articles in Medicine and Health Sciences

Oncolog, Volume 62, Number 11-12, November - December 2017, Joe Munch, Bryan Tutt Nov 2017

Oncolog, Volume 62, Number 11-12, November - December 2017, Joe Munch, Bryan Tutt

OncoLog MD Anderson's Report to Physicians (All issues)

  • Managing Chemotherapy-Induced Neuropathy: Neuromodulation, pharmacological treatments show promise against peripheral neuropathy in cancer patients.
  • Treating Tobacco Addiction: MD Anderson provides pharmacotherapy, counseling to help smokers quit plus cessation education, resources for community practitioners
  • HOUSE CALL: Smoking-Related Cancers- Cancer risks from tobacco are not limited to the lungs, but quitting reduces these risks


Oncolog, Volume 62, Number 10, October 2017, Sarah Bronson, Bryan Tutt Oct 2017

Oncolog, Volume 62, Number 10, October 2017, Sarah Bronson, Bryan Tutt

OncoLog MD Anderson's Report to Physicians (All issues)

  • Organ-Sparing Therapy for Esophageal Cancer: Endoscopic surgery, ablation treat early-stage cancer, dysplasia while avoiding esophagectomy.
  • INBRIEF: Surgeons Perform Unique Allogeneic Soft Tissue Transplant Between Identical Twins
  • Advances in Breast Reconstruction: New reconstruction techniques increase breast cancer surgical options, improve cosmetic outcomes.
  • HOUSE CALL: Facing the Financial Burden of Cancer Treatment-Talking to care team, seeking out resources are important steps in managing cancer-related financial stress
  • INBRIEF: Proton Therapy plus Chemotherapy Shows Promise in Lung Cancer Trial


Oncolog, Volume 62, Number 08, August 2017, Bryan Tutt, Sarah Bronson Aug 2017

Oncolog, Volume 62, Number 08, August 2017, Bryan Tutt, Sarah Bronson

OncoLog MD Anderson's Report to Physicians (All issues)

  • Immunotherapy for Smoldering Myeloma: Clinical trials test PD-1, DC38 inhibitors to delay progression from premalignant disease to multiple myeloma.
  • Malignant Pheochromocytoma and Sympathetic Paraganglioma Research: Studies may expand treatment options for patients with rare neuroendocrine tumors.
  • Hypofractionated Partial-Breast Irradiation: Clinical trial tests 10-day external-beam radiation therapy regimen after lumpectomy for patients with early-stage breast cancer.
  • HOUSE CALL: Support for Cancer Patients: Patients, caregivers find many types of support from various organizations


Oncolog, Volume 62, Number 07, July 2017, Joe Munch, Bryan Tutt Jul 2017

Oncolog, Volume 62, Number 07, July 2017, Joe Munch, Bryan Tutt

OncoLog MD Anderson's Report to Physicians (All issues)

  • RAS Mutations and Colorectal Cancer Liver Metastases: Gene mutations may have implications for local therapy for liver metastases from colorectal cancer.
  • Active Surveillance for Prostate Cancer: Clinical trial may clarify which patients with prostate cancer will benefit from active surveillance rather than immediate treatment.
  • Gut Microbiome May Affect Immunotherapy Response in Melanoma: Metastatic melanoma patients who experience responses to checkpoint inhibitors have a distinct gut bacterial genetic signature.
  • HOUSE CALL: Cancer-Related fatigue-Tips for fighting fatigue


Oncolog, Volume 62, Number 04, April 2017, Bryan Tutt, Sarah Bronson Apr 2017

Oncolog, Volume 62, Number 04, April 2017, Bryan Tutt, Sarah Bronson

OncoLog MD Anderson's Report to Physicians (All issues)

  • Advances in Surgical Management of Lymphedema: New options reduce edema in limbs, improve quality of life for cancer patients with lymphedema.
  • Noncytotoxic First-Line Therapy for Mantle Cell Lymphoma: First-line therapy with targeted and immunotherapy agents produces high response rates in mantle cell lymphoma.
  • Reports from the Survivorship Research Symposium: Research on BK virus, heart failure, and aspiration in cancer survivors.
  • HOUSE CALL: Types of Immunotherapy for Cancer: Understanding different approaches to immunotherapy